Giacomo Miserocchi - Concepedia

Author

Giacomo Miserocchi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ORCID

Also Known As

Alberto Micco, G. Miserocchi, Giacomo Miserocchi, Miserocchi G, Miserocchi, G.

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico Ospedale G.B. Morgagni - L.Pierantoni Istituto Ortopedico Rizzoli University of Bologna

About

Giacomo Miserocchi is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	412
2	Health Sciences	2	2	128
3	Engineering	1	1	69
4	Social Sciences	1	1	33
5	Biomedical Engineering	1	1	69

Giacomo Miserocchi

Publications

932

Citations

H-Index

Page 1

	Year	Citations
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model Laura Mercatali, Federico La Manna, Arwin Groenewoud, International Journal of Molecular Sciences Breast OncologyCell ProliferationPatient-derived XenograftCancer BiologyTumor Biology	2016	99
Investigating the Mechanobiology of Cancer Cell–ECM Interaction Through Collagen-Based 3D Scaffolds Chiara Liverani, Laura Mercatali, Luca Cristofolini, Cellular and Molecular Bioengineering Tissue EngineeringScaffoldsCollagen-based 3DBiomaterialsEngineering	2017	69
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer Alessandro De Vita, Chiara Liverani, Roberto Molinaro, Scientific Reports	2021	59
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient‐derived primary culture case series in tridimensional and zebrafish models Alessandro De Vita, Federica Recine, Giacomo Miserocchi, Journal of Experimental & Clinical Cancer Research	2021	49
A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences Alessandro De Vita, Silvia Vanni, Giacomo Miserocchi, Biomedicines	2022	47
Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas Giacomo Miserocchi, Claudia Cocchi, Alessandro De Vita, Cancer Biology and Medicine	2021	45
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms Chiara Liverani, Alberto Bongiovanni, Laura Mercatali, Endocrine Pathology Endocrine OncologyGastroenteropancreatic Neuroendocrine NeoplasmsMedicineGastroenterologyPathology	2021	44
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents Alessandro De Vita, Federica Recine, Laura Mercatali, International Journal of Molecular Sciences Malignant DiseaseMedicinePathologyPleomorphic SarcomaPrimary Culture	2017	39
Temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A “Real-World” Data Analysis Alberto Bongiovanni, Chiara Liverani, Flavia Foca, Neuroendocrinology	2020	35
Myxofibrosarcoma primary cultures: molecular and pharmacological profile Alessandro De Vita, Federica Recine, Laura Mercatali, Therapeutic Advances in Medical Oncology	2017	34

Page 1